HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angiotensin II type 2 receptor signaling affects dopamine levels in the brain and prevents binge eating disorder.

AbstractINTRODUCTION:
Binge eating disorder (BED) is associated with dopaminergic activation as food reward, resulting in metabolism-related disorders. Stimulation of angiotensin type 2 (AT2) receptor is reported to inhibit dopamine synthesis. We investigated the possible roles of AT2 receptor-mediated dopamine regulation in the pathogenesis of BED.
MATERIALS AND METHODS:
Male C57BL/6 mice, type 2 diabetic (KKAy) mice and AT2 receptor-null (AT2KO) mice at eight weeks old were treated with AT2 receptor agonist, compound 21 (C21) or saline for two weeks. Mice were subjected to fasting for two days followed by re-feeding for seven days.
RESULTS:
Treatment with C21 attenuated the rebound proportion of body weight, food intake and water intake in KKAy mice, but not in C57BL/6 and AT2KO mice. Dopamine concentration in the striatum was further increased by fasting in KKAy and AT2KO mice. Administration of C21 significantly attenuated this fasting-induced increase in dopamine level only in KKAy mice. Dopamine receptor D1, D2 expression in the substantia nigra were markedly lower in KKAy mice compared with C57BL/6 mice, while administration of C21 increased their expression in KKAy mice.
CONCLUSIONS:
Our study suggests that AT2 receptor stimulation may be a new therapeutic approach to improve eating disorder associated with dopamine resistance.
AuthorsHirotomo Nakaoka, Masaki Mogi, Harumi Kan-No, Kana Tsukuda, Kousei Ohshima, Xiao-Li Wang, Toshiyuki Chisaka, Hui-Yu Bai, Bao-Shuai Shan, Masayoshi Kukida, Jun Iwanami, Masatsugu Horiuchi
JournalJournal of the renin-angiotensin-aldosterone system : JRAAS (J Renin Angiotensin Aldosterone Syst) Vol. 16 Issue 4 Pg. 749-57 (Dec 2015) ISSN: 1752-8976 [Electronic] England
PMID25757658 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author(s) 2015.
Chemical References
  • Receptor, Angiotensin, Type 2
  • Receptors, Dopamine
  • Dopamine
Topics
  • Animals
  • Behavior, Animal
  • Binge-Eating Disorder (metabolism)
  • Blood Pressure
  • Brain (metabolism)
  • Diabetes Mellitus, Experimental (metabolism, pathology)
  • Dopamine (metabolism)
  • Fasting
  • Gene Deletion
  • Immunohistochemistry
  • Male
  • Mice, Inbred C57BL
  • Neostriatum (metabolism)
  • Receptor, Angiotensin, Type 2 (metabolism)
  • Receptors, Dopamine (metabolism)
  • Signal Transduction
  • Systole
  • Weight Gain

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: